Navigation Links
China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol 'NBS'
Date:10/29/2009

NEW YORK, Oct. 29 /PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdings, Inc. (OTC Bulletin Board: CHBP), an integrated bio-pharmaceutical company, based in the People's Republic of China, announced today that its shareholders have approved the acquisition of CHBP by NeoStem, Inc. (NYSE AMEX: NBS) by an overwhelming vote in favor of approximately 80% of all issued and outstanding shares. The approval was obtained at a Special Meeting of Stockholders held today.

The acquisition will add significant potential benefits to the growth prospects of Suzhou Erye Pharmaceuticals Company Ltd. ("Erye"), CHBP's primary asset, including:

    A.  Benefits associated with being part of a publicly traded NYSE AMEX
        listed company.
    B.  Enhanced distribution channels with global market potential.
    C.  Leadership by an internationally recognized medical advisory board and
        executive management team led by Dr. Robin L. Smith, an experienced
        healthcare executive, who will be overseeing the combined operations.
    D.  Significant growth opportunities in the rapidly developing Stem Cell
        treatment and therapy segment of healthcare.
    E.  Enables the combined entity to source drugs and treatments from each
        other's pipeline.
    F.  Enhances company transparency and corporate governance enabling
        greater visibility in capital markets.

The Merger will expand the business potential and drug development opportunities with the addition of NeoStem's innovative Stem Cell therapy treatments. The expanded channels of development and distribution should boost the Company's portfolio of over 100 drugs on seven GMP lines, while benefiting distribution channels globally.

Madame Zhang, General Manager of Erye, said, "This Merger will allow us to expand the business potential of Eyre
'/>"/>

SOURCE China Biopharmaceuticals Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  Hologic, Inc. (NASDAQ: HOLX ) announced today ... ended June 27, 2015.  Quarterly revenues of $693.9 million ... a constant currency basis.  GAAP earnings per share (EPS) ... increased 16.2%. "Our third quarter financial results ... a company that can grow sustainably on both the ...
(Date:7/29/2015)... Inc. (Vanda) (NASDAQ: VNDA ), today announced financial ... 30, 2015. "We are impressed with U.S. ... H. Polymeropoulos M.D., Vanda,s President and CEO, "further investments ... products set the stage for the next level of ... , Total net product sales for the second quarter ...
(Date:7/29/2015)... 2015 Sangamo BioSciences, Inc. (NASDAQ: SGMO ... second quarter 2015 financial results after the market closes ... be followed by a conference call at 5:00 p.m. ... telephone and webcast. During the conference call, the company ... business matters. The conference call dial-in numbers ...
Breaking Medicine Technology:Hologic Announces Financial Results for Third Quarter of Fiscal 2015 2Hologic Announces Financial Results for Third Quarter of Fiscal 2015 3Hologic Announces Financial Results for Third Quarter of Fiscal 2015 4Hologic Announces Financial Results for Third Quarter of Fiscal 2015 5Hologic Announces Financial Results for Third Quarter of Fiscal 2015 6Hologic Announces Financial Results for Third Quarter of Fiscal 2015 7Hologic Announces Financial Results for Third Quarter of Fiscal 2015 8Hologic Announces Financial Results for Third Quarter of Fiscal 2015 9Hologic Announces Financial Results for Third Quarter of Fiscal 2015 10Hologic Announces Financial Results for Third Quarter of Fiscal 2015 11Hologic Announces Financial Results for Third Quarter of Fiscal 2015 12Hologic Announces Financial Results for Third Quarter of Fiscal 2015 13Hologic Announces Financial Results for Third Quarter of Fiscal 2015 14Hologic Announces Financial Results for Third Quarter of Fiscal 2015 15Hologic Announces Financial Results for Third Quarter of Fiscal 2015 16Hologic Announces Financial Results for Third Quarter of Fiscal 2015 17Hologic Announces Financial Results for Third Quarter of Fiscal 2015 18Hologic Announces Financial Results for Third Quarter of Fiscal 2015 19Hologic Announces Financial Results for Third Quarter of Fiscal 2015 20Hologic Announces Financial Results for Third Quarter of Fiscal 2015 21Hologic Announces Financial Results for Third Quarter of Fiscal 2015 22Hologic Announces Financial Results for Third Quarter of Fiscal 2015 23Hologic Announces Financial Results for Third Quarter of Fiscal 2015 24Hologic Announces Financial Results for Third Quarter of Fiscal 2015 25Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 12
... ELKRIDGE, Md., Sept. 27, 2011 GP ... company of global performance improvement solutions provider General Physics ... has authorized a $5 million share repurchase program, replacing ... GP Strategies, share repurchase program allows management, at its ...
... of jobs in Michigan supported by the biopharmaceutical research ... as imposing new taxes in the Medicare prescription drug ... From research to technical work, manufacturing to construction and ... the biopharmaceutical sector supports a broad array of high-quality ...
Cached Medicine Technology:GP Strategies Announces $5 Million Share Repurchase Program 2Research Demonstrates Possible Michigan Job Losses from Sectors Supported by Biopharmaceutical Companies 2Research Demonstrates Possible Michigan Job Losses from Sectors Supported by Biopharmaceutical Companies 3
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... production, announced today that Columbia University Medical Center, located in New York, NY, ... studio makes it easy for physicians and scientists to immediately access worldwide TV ...
(Date:7/29/2015)... ... July 29, 2015 , ... Andrzej Klos, M.D., has been reviewed ... pediatrician for nearly 38 years, is motivated each and every day by his sincere ... profession shine alongside his many awards and accolades, which include multiple listings in many ...
(Date:7/29/2015)... ... July 29, 2015 , ... " Core Organizer ” ... at the latest and coolest applications on the market for iOS, Android, and Windows. ... shared with viewers how this app will help anyone get organized. , Wouldn’t it ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... therapeutic development for Atherosclerosis. Atherosclerosis is a slow, progressive disease that may start ... to produce first-in-class and best-in-class products. Complete report on Atherosclerosis Pipeline with 78 ...
(Date:7/29/2015)... ... July 29, 2015 , ... Topical ... its Topricin® Pain Relief and Healing Cream designated as the nonprofit’s natural pain ... is actively addressing Line of Duty Deaths (LODD) and the high rate of ...
Breaking Medicine News(10 mins):Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Get More Organized with the Core Organizer App 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6
... Medical,Association (AVMA) is joining other U.S. public health organizations in ... National,Handwashing Awareness Week, December 7-13. , ... due to a flu vaccine shortage,in Cincinnati, National Handwashing Awareness ... According to Dr. James O. Cook, president ...
... Study says metabolic abnormalities better regulated when following this ... older adults at risk for heart disease, a Mediterranean ... manage metabolic syndrome, according to a Spanish study. ... that includes abdominal obesity, high cholesterol, high blood pressure ...
... Mich. A new study from researchers at the University ... used by doctors to estimate the risk of a woman,s ... explaining risk to patients. As a result, women with breast ... to have chemotherapy. , The tool itself is very useful ...
... Hutch Holiday Gala raised more,than $2.2 million for cancer and ... "Help the Hutch," a portion ... for specific contribution levels, brought in $1.2 million to,be directed ... battle cancer. , The ...
... an authoritative guide explaining the causes of hair loss and ... , NEW YORK, Dec. 8 Renowned hair ... Rassman, have co-authored the first authoritative, but user-friendly guide, to ... and their medical and hair transplant options. The book, ...
... WASHINGTON, Dec. 8 OECD,s latest survey of the United ... assesses the challenges facing the new administration amid a ... achieving universal healthcare. The Washington D.C. launch will be held ... Dec 9 and will offer first a panel discussion to ...
Cached Medicine News:Health News:Veterinarians Stress Importance of Handwashing 2Health News:Mediterranean Diet Enriched With Nuts Cuts Heart Risks 2Health News:Confusing risk information may lead breast cancer patients to make poor treatment choices 2Health News:Confusing risk information may lead breast cancer patients to make poor treatment choices 3Health News:33rd Annual Hutch Holiday Gala Raises Millions for Cancer Immunotherapy Research 2Health News:33rd Annual Hutch Holiday Gala Raises Millions for Cancer Immunotherapy Research 3Health News:Hair Transplant Surgeons Author Hair Loss for Dummies Book 2Health News:Hair Transplant Surgeons Author Hair Loss for Dummies Book 3Health News:OECD Economic Survey of the United States 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: